1-3 of 3
Jeremiah D Degenhardt, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development Of Methods To Perform Next Generation Sequencing (NGS)-Based Genomics Studies On Multiple Myeloma Clinical Samples

Jonathan J Keats, PhD, Kevin A Kwei, PhD, Jeremiah D Degenhardt, Ph.D., Kristi Allen, BS, Christopher J. Kirk, Ph.D, Brian B Tuch, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 5347.
https://doi.org/10.1182/blood.V122.21.5347.5347
Published: 2013
Journal Articles

Immunoglobulin Expression Is a Major Determinant Of Patient Sensitivity To Proteasome Inhibitors

Brian B Tuch, Ph.D., Andrea Loehr, Ph.D., Jeremiah D Degenhardt, Ph.D., Kevin A Kwei, PhD, Jonathan J Keats, PhD, Christopher J. Kirk, Ph.D
Journal: Blood
Blood (2013) 122 (21): 1903.
https://doi.org/10.1182/blood.V122.21.1903.1903
Published: 2013
Journal Articles

A Method To Identify Copy Number Aberrations (CNAs) From Whole Exome Sequence (WES) Data and Its Application To Multiple Myeloma Cell Lines and Patient Samples

Jeremiah D Degenhardt, Ph.D., Kenneth B Hoehn, Kevin A Kwei, Ph.D., Jonathan J Keats, PhD, Christopher J. Kirk, PhD, Brian B Tuch, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 4881.
https://doi.org/10.1182/blood.V122.21.4881.4881
Published: 2013